Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation

A Randomized Study for Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Patients Preparing for Kidney Transplantation

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02782416

Enrollment

800

Registered

2016-05-25

Start date

2014-01-31

Completion date

2017-12-31

Last updated

2016-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplantation

Keywords

Renal, Latent, Tuberculosis

Brief summary

Study the prevalence of LTBI in patients who are waiting renal transplant and monitor the incidence of active TB

Detailed description

Study the prevalence of LTBI in patients who are waiting renal transplant and monitor the incidence of active TB

Interventions

OTHERExamination of latent tuberculosis

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 65 Years

Healthy volunteers

Inclusion criteria

1. Age between 20-65 and match one of below 2. Waiting renal transplant or status post renal transplant 3. Receiving long term dialysis

Exclusion criteria

1. Not agree to be enrolled 2. Suspected active TB 3. HIV patients 4. Viral hepatitis 5. Using immunosuppressants within 3 months before enrollment 6. Receiving lymphokine therapy 7. Hemoglobin \< 8 g/dL 8. Serum bilirubin \> 2.5 mg/dL 9. AST or ALT \> 2 times of upper normal limit 10. Lactation or pregnancy

Design outcomes

Primary

Measure	Time frame
percentage of active TB	4 years

Countries

Taiwan

Contacts

Primary ContactChin-Chung Shu, MD

ccshu139@ntu.edu.tw+886972653087

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026